Old Drugs, New Disease

The diabetes drugs that transformed weight loss may be key to treating addiction, too. Dr. Sanjay Gupta speaks with Dr. Dhruv Khullar about how GLP-1s affect the brain, its reward system, and maybe even addiction. This episode was produced by Jennifer Lai with assistance from Sof ...  Show more

An FDA panel has recommended allowing compounding pharmacies to make six unapproved peptides. Dr. Sanjay Gupta and CNN Health's John Bonifield discuss their popularity, safety concerns and what comes next. This episode was produced by Madeleine Thompson and Leying Tang. Medical W ...  Show more

As a number of existing therapies are being re-purposed to help patients with the most severe Covid-19 symptoms, we speak to a UK-based bioscience company about a drug they've developed and explore how it is being used in Italy. Guests: Tom Whipple, The Times science editorSomeit ...  Show more

Smitha Mundasad asks whether we will see waves of Covid – with infections going up and down and then up and down again - forever more. We speak to Elliot whose life has been transformed after a single shot of gene therapy to treat the inherited blood disorder haemophilia B. And D ...  Show more

Chloroquine and hydroxychloroquine - two drugs touted by U.S. President Donald Trump, who says they could be game changing treatments for COVID-19. But around the world health experts have tried to temper expectations for these medications. Today, on Front Burner, we talk to infe ...  Show more

In this Journal Jam podcast we dig deep into the science of FDA-approved outpatient medications for COVID with 3 critical appraisal masters: Dr. Andrew Morris, Dr. Rohit Mohindra and Dr. Justin Morgenstern. What is the evidence for the neutralizing monoclonal antibody medications ...  Show more